Compare Amylx Pharmaceuticals Inc (AMLX) vs NetEase Inc (NTES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs NetEase Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while NetEase Inc trades at $122.96 (market cap $82.75B). The key difference: NetEase Inc is far larger — about 31.3× Amylx Pharmaceuticals Inc's market cap, and NetEase Inc pays a 2.36% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | NTES | |
|---|---|---|
Market Cap | $2.64B | $82.75B |
Sector | Health | Media |
52-Week High | $24.19 | $159.34 |
52-Week Low | $7.82 | $109.26 |
Enterprise Value | $2.39B | $59.05B |
Dividend Yield | — | 2.36% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →
